Baudax Bio Inc (BXRXQ)
OTCMKTS: BXRXQ · Delayed Price · USD
0.0070
0.00 (0.00%)
Jun 20, 2024, 12:00 AM EDT - Market closed

Baudax Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current2022202120202019
Market Capitalization
02192765
Market Cap Growth
--91.41%-30.17%-59.41%-
Enterprise Value
8411548
PE Ratio
0.00-0.03-0.94-0.35-2.01
PS Ratio
0.181.2517.1453.76-
PB Ratio
-0.25-0.071.40-1.79-3.90
P/FCF Ratio
-0.56-0.06-0.37-0.59-1.27
P/OCF Ratio
-0.56-0.06-0.38-0.60-1.30
EV/Sales Ratio
25.133.3610.3210.77-
EV/EBITDA Ratio
-1.49-0.08-0.66-0.07-1.51
EV/EBIT Ratio
-1.44-0.07-0.56-0.07-1.48
EV/FCF Ratio
-2.22-0.15-0.23-0.12-0.94
Debt / Equity Ratio
-0.79-0.330.65-0.62-0.05
Debt / EBITDA Ratio
-1.17-0.14-0.50-0.13-0.02
Debt / FCF Ratio
-1.74-0.29-0.17-0.20-0.02
Quick Ratio
0.020.251.051.682.30
Current Ratio
0.070.301.502.032.61
Asset Turnover
0.020.040.020.010
Interest Coverage
----55.00-
Return on Equity (ROE)
54.50%789.00%605.10%196.00%76.50%
Return on Assets (ROA)
-48.50%-200.70%-30.00%-108.80%-73.00%
Return on Capital (ROIC)
1138.11%365.37%-240.73%988.26%295.17%
Earnings Yield
-12787.14%-3697.11%-106.83%-287.16%-49.86%
FCF Yield
-8304.94%-1748.92%-267.34%-168.66%-78.92%
Buyback Yield / Dilution
-2601.40%-505.82%-311.07%-99.37%-
Total Shareholder Return
-2601.40%-505.82%-311.07%-99.37%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).